Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer
Yu Zhang, Fei Wang, Haoran Sun, Yakai Huang, Jianpeng Gao, Hua Huang
Topics & Concepts
Cytotoxic T cellApatinibCD20CD8Cancer researchImmune systemMedicineTumor microenvironmentCombination therapyFOXP3ImmunologyCancerAntibodyPharmacologyChemistryInternal medicineIn vitroBiochemistryCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCholangiocarcinoma and Gallbladder Cancer Studies